Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyapatite crystal matrix is the principal inorganic component of bones and teeth, conferring rigidity and structural strength. Its chemical composition is calcium phosphate, Ca₁₀(PO₄)₆(OH)₂, forming nanoscale plate or needle-like crystals, frequently organized along type I collagen fibers. This matrix provides mechanical support and acts as a calcium and phosphate reservoir. Hydroxyapatite in bone is often defective or carbonated, differing from synthetic, stoichiometric hydroxyapatite. In bone regeneration therapies, synthetic or natural hydroxyapatite is used as a scaffold to promote new bone growth. Pathologically, hydroxyapatite crystals can accumulate in certain diseases, such as calcific tendonitis or tumors. While the hydroxyapatite matrix itself is not a therapeutic target, it is critical in understanding bone physiology, pathology, and therapeutic interventions.
Adsorption to crystal surface (bisphosphonates attach to hydroxyapatite, preventing osteoclast-mediated dissolution); Incorporation as scaffold/material in bone regeneration therapies
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite crystal matrix (HA or HAp).